Dr Max Noble 

Biography

Dr Max Noble is the CEO of VISFO; a health technology firm based in the UK. Max has degrees in Medicinal Chemistry, Chemical Engineering (Manchester) and Health Economics (York). With over 30 years’ experience in healthcare industries, Max and has team are experts in health outcomes research, pharmacoepidemiology, the application of advanced health economic approaches such as discrete choice experiments and discrete event modelling. 

With early career experience in clinical (Glaxo-Wellcome), Max spent two years in SmithKline Beecham’s Global Pricing and Health Economics group.  For over 20 years Max has consulted globally, working on early access programmes, launch excellence, health technology assessment and software development.  Max leads a team of over 40 scientists from statistics, machine learning, data science, biomedical science, and software engineering to support all aspect of clinical and real-world evidence development.  Max and his team worth with global Pharmaceutical and Medical Device companies and academia.

Participation

Since 2021 Max has funded the Enigma Scholarship, 18 undergraduates as part of the widening participation agenda within York, funded two MRes students with a focus on the inflammasomes to unpick early mechanisms in Lupus. Moving forward VISFO is funding an industrial PhD within the Psychology department examining misinformation along with a group of PhDs with Dr Jillian Barlow as part of Generation Research.  Each year VISFO has worked with the careers department on the IntoTech programme and the STEM careers programme.